Giant Cell Arteritis

Introduction

Giant cell arteritis is a chronic systemic vasculitis involving medium and large arteries. It is a disease of older adults with the greatest incidence occurring in patients older than 70 and is almost never seen in people under 50 (1). Cranial branches of the carotid artery are commonly affected. Due to the superficial location of the superficial temporal artery it is the most common site for vascular biopsy to confirm the diagnosis (2). This is probably why it is often referred to as temporal arteritis. If left untreated over one third of patients experience permanent visual loss, hence the importance of timely recognition, diagnosis and management.

Clinical Features

 

Risk Factors

  • Age

  • Northern European ancestry

  • Female gender (F:M = 3:1)

  • Family history

  • Polymyalgia rheumatica (PMR)

 
 
 
 

Signs

Clinical examination may be completely normal however the presence of the following findings increases the chances of having a positive temporal artery biopsy.

  • Tenderness over the temporal arteries (+ve LR 2.6)

  • Loss of pulsation of the temporal artery (+ve LR 2.7)

  • Prominent / enlarged temporal artery (+ve LR4.3)

Other large and medium size arteries other than the cranial arteries can be affected leading to the below findings

  • Aortic regurgitation – suggests development of aortic artery aneurysm and significant aortitis

  • Abnormal pulses

Symptoms

  • Headache (80%)

    • New headache

    • Often unilateral but can be sometimes be generalized

    • Can be progressively worsening, waxing and waning or constant

  • Jaw claudication (50% of patients)

  • Fatigue

  • Fever

  • Weight loss

  • Night sweats

  • Diplopia

  • Amaurosis fugax

 

Complications

Permanent vision loss

  • Can be unilateral or bilateral

  • May be preceded by transient visual loss

  • Once established is rarely reversible and the second unaffected eye often is involved within a week of initial visual loss

  • High dose glucocorticoids almost completely remove the risk of visual loss while vision is still in tact

Other complications

  • Dependent on what other vessels are involved

Differential Diagnosis

 

Headache

  • Primary headache disorder

    • Tension / migraine

  • Symptomatic severe hypertension

  • Intracranial bleed

  • Acute angle closure glaucoma

  • Space occupying lesion

  • Meningitis / encephalitis

Eye Symptoms

  • Stroke / TIA

  • Ischaemic optic neuropathies

Clinical Investigations

 
bloods%2B%252B%2Bpod.jpg

Bedside & Laboratory

  • BM – should check baseline in case steroids treatment is required. Steroids can cause significant changes in blood sugar

  • ESR

    • usually but not always significantly raised, one study found 5% of patients with biopsy proven GCA had an ESR of less than 40 (3)

    • FBC / U&E / Coag useful in the management of other differentials

 
 
LP%252Bequipment.jpg

Other

Temporal artery biopsy is the gold standard diagnostic test

  • Initially a unilateral temporal artery biopsy is performed

  • Due to ‘skip lesions’ a negative biopsy does not rule out the diagnosis if there is a very high clinical suspicion

  • If clinical suspicion is very high and initial biopsy is negative a contralateral biopsy may be performed

Screenshot 2021-02-10 at 15.10.07.png

Radiologic

  • Colour doppler ultrasound (CDUS) has been proposed as an alternative to the traditional temporal artery biopsy

    • Studies have shown consistently high specificity when compared with temporal artery biopsy however the sensitivities have been widely variable (4)

    • This would suggest that CDUS may be a useful rule in test however due to inter-operator variability is unlikely to be useful in ruling out the diagnosis of GCA

  • If other large vessel involvement is suspected (for example the aortic arch) then CT angiography is necessary

  • Central CT or MR imaging is not useful in diagnosing GCA however, depending on the clinical situation may be required to rule out other differentials

Treatment & Disposition

 

Symptomatic treatment

  • Simple analgesia can be given for headache symptoms

    • Paracetamol 1g po     

    • Ibuprofen 400mg po

Specific Treatment

  • High dose steroids – prednisolone 1mg/kg to a max of 60mg

    • They should be started as soon as the diagnosis is strongly suspected but most importantly should not be delayed in patients with threatened or recent vision loss

    • While high dose steroids can have significant side effects particularly in older adults if the diagnosis is highly suspected they should be initiated immediately while awaiting confirmatory temporal artery biopsy

    • Histopathologic evidence of GCA will be present for at least a month after starting steroid treatment

  • In patients with severe adverse reactions to steroids alternative agents such as methotrexate or tocilizumab may be used (5)

Disposition

  • If timely follow-up with temporal artery biopsy to confirm the diagnosis can be confirmed patients can be discharged on high dose prednisolone

  • If timely follow-up cannot be arranged or life-threatening differentials cannot be ruled out patients may require admission for diagnostic work up

 

 

References

  1. Mann CJ. RCEM Learning; Secondary Headahce. [Online].; 2015 [cited 2020 October. Available from: https://www.rcemlearning.co.uk/modules/secondary-headache/.

  2. Docken WP, Rosenbaum JT. Clinical manifestations of giant cell arteritis. In UptoDate.: https://www.uptodate.com/contents/clinical-manifestations-of-giant-cell-arteritis?search=temporal%20arteritis&source=search_result&selectedTitle=3~133&usage_type=default&display_rank=3; 2019.

  3. Salvarani C, Hunder GG. Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurence in a population-based study. Arthritis & Rheumatology. 2001 April; 45(2).

  4. Arida A, Kyprianou M, Kanakis M, Sfikakis PP. The diagnostic value of ultrasonography-derived oedema of the temporal artery wall in giant cell arteritis: a second meta-analysis. BMC Musculoskeletal Disorders. 2010 March; 11(44).

  5. Docken WP, Trobe J, Matteson EL, Curtis MR. Treatment of giant cell arteritis. [Online].; 2020 [cited 2021 February 13. Available from: https://www.uptodate.com/contents/treatment-of-giant-cell-arteritis?search=giant%20cell%20arteritis&source=search_result&selectedTitle=2~138&usage_type=default&display_rank=2#H4271942575.

 

This blog was written by Dr. Emer Kidney and was last updated in February 2021

Before you go have another look at the clinical case and see have your answers to any of the questions changed and if so how?